127 related articles for article (PubMed ID: 16679562)
1. New imidazole-coordinated chemotherapeutics with low epithelial toxicity.
Ludwig T; Fakih S; Bertram H; Krebs B; Oberleithner H
Cell Biochem Biophys; 2006; 45(1):31-41. PubMed ID: 16679562
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.
Ludwig T; Riethmüller C; Gekle M; Schwerdt G; Oberleithner H
Kidney Int; 2004 Jul; 66(1):196-202. PubMed ID: 15200426
[TBL] [Abstract][Full Text] [Related]
3. Platinum complex toxicity in cultured renal epithelia.
Ludwig T; Oberleithner H
Cell Physiol Biochem; 2004; 14(4-6):431-40. PubMed ID: 15319547
[TBL] [Abstract][Full Text] [Related]
4. Structure-toxicity relationships for different types of dinuclear platinum complexes.
Kalayda GV; Fakih S; Bertram H; Ludwig T; Oberleithner H; Krebs B; Reedijk J
J Inorg Biochem; 2006 Aug; 100(8):1332-8. PubMed ID: 16684566
[TBL] [Abstract][Full Text] [Related]
5. Platinum complex cytotoxicity tested by the electrical resistance breakdown assay.
Ludwig T; Fakih S; Krebs B; Oberleithner H
Cell Physiol Biochem; 2004; 14(4-6):425-30. PubMed ID: 15319546
[TBL] [Abstract][Full Text] [Related]
6. In vitro toxicological evaluation of a dinuclear platinum(II) complex with acetate ligands.
Momekov G; Ferdinandov D; Bakalova A; Zaharieva M; Konstantinov S; Karaivanova M
Arch Toxicol; 2006 Sep; 80(9):555-60. PubMed ID: 16485120
[TBL] [Abstract][Full Text] [Related]
7. Organic cation transporters are determinants of oxaliplatin cytotoxicity.
Zhang S; Lovejoy KS; Shima JE; Lagpacan LL; Shu Y; Lapuk A; Chen Y; Komori T; Gray JW; Chen X; Lippard SJ; Giacomini KM
Cancer Res; 2006 Sep; 66(17):8847-57. PubMed ID: 16951202
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells.
Gassama-Diagne A; Yu W; ter Beest M; Martin-Belmonte F; Kierbel A; Engel J; Mostov K
Nat Cell Biol; 2006 Sep; 8(9):963-70. PubMed ID: 16921364
[TBL] [Abstract][Full Text] [Related]
9. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
Yonezawa A; Inui K
Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
[TBL] [Abstract][Full Text] [Related]
10. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
11. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of cell injury after exposure to antitumor platinum derivatives in kidney tubular epithelial cells.
Kitada N; Takara K; Itoh C; Minegaki T; Tsujimoto M; Sakaeda T; Yokoyama T
Chemotherapy; 2008; 54(3):217-23. PubMed ID: 18560229
[TBL] [Abstract][Full Text] [Related]
14. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
Zhang J; Li Y; Sun J
Eur J Med Chem; 2009 Jun; 44(6):2758-62. PubMed ID: 19056150
[TBL] [Abstract][Full Text] [Related]
17. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a matrix-associated transepithelial resistance invasion assay to precisely measure the invasive potential of synovial fibroblasts.
Wunrau C; Schnaeker EM; Freyth K; Pundt N; Wendholt D; Neugebauer K; Hansen U; Pap T; Dankbar B
Arthritis Rheum; 2009 Sep; 60(9):2606-11. PubMed ID: 19714628
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
20. Side-specific effects by cadmium exposure: apical and basolateral treatment in a coculture model of the blood-air barrier.
Papritz M; Pohl C; Wübbeke C; Moisch M; Hofmann H; Hermanns MI; Thiermann H; Kirkpatrick CJ; Kehe K
Toxicol Appl Pharmacol; 2010 Jun; 245(3):361-9. PubMed ID: 20399800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]